Clinical Trial Update: Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/3 trial evaluating SPH4336 in combination with endocrine therapy for locally advanced or metastatic breast cancer; no results reported yet a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• SPH4336

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: Locally Advanced or Metastatic Breast Cancer | Phase 2, Phase 3 | Status: RECRUITING